Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Loteprednol vs Fluorometholone after PRK
NCT02974387Phase 4Unknown
- Sponsor
- Salouti Eye Research Center
- Start
- Apr 2017
- Primary completion
- Aug 2017
- Modality
- Orthosteric Ligands
01
Overview
Phase 4, randomised, single-blind trial of loteprednol etabonate in myopia (2 arms), sponsored by Salouti Eye Research Center. Primary endpoint: Time to re-epithelialization. Status: unknown.
02
Drugs
loteprednol etabonate
03
Conditions
myopia
Beyond the preview
Go deeper on NCT02974387.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02974387.